InVasc Therapeutics invasc.net


Public lists: Pharma Startups (4732)

InVasc Therapeutics specializes in target-specific drug discovery and has developed a approach to drug discovery that uses molecular structures and an application-based platform that decreases the time and expense of current large-scale "mining"� discovery techniques. The InVasc process is the result of university-based research at Emory University and The Ohio State University.

InVasc Therapeutics specializes in target-specific drug discovery and has developed a approach to drug discovery that uses molecular structures and an application-based platform that decreases the time and expense of current large-scale "mining"ï¿...Show all

Company (Alive / Active)

Phone: 678-736-5903

Fax:

3562 Habersham AT Northlake
Building J, Suite A
Tucker, 30084
Georgia, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
InVasc Therapeutics $3.6M Jul 19, 2010
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related InVasc Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 3 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

Archemix

San Francisco, California, United States
Alive / ActiveArchemix discovers, develops, and commercializes therapeutic aptamers for the prevention and treatment of chronic and acute diseases. The Company's aptamer product candidates include ARC1779 for thrombotic microangiopathyies and carotid endarterectomy surgical procedure. The company also offers product candidates for cardiovascular, hematology, and oncology diseases.Login to see details

Astex Pharmaceuticals

Cambridge, England, United Kingdom
AcquiredAstex is a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics for oncology and diseases of the central nervous system.Login to see details
See all 15 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Methylenedioxy phenolic compounds and their use to treat disease Aug 05, 2009 Jun 12, 2012 Patent